LL-37 peptide
Selected indexed studies
- Cathelicidin LL-37: a multitask antimicrobial peptide. (Arch Immunol Ther Exp (Warsz), 2010) [PMID:20049649]
- Rosacea: Pathogenesis and Therapeutic Correlates. (J Cutan Med Surg, 2024) [PMID:38450615]
- Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis. (Arch Immunol Ther Exp (Warsz), 2025) [PMID:40960088]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rosacea: Pathogenesis and Therapeutic Correlates. (2024) pubmed
- Cathelicidin LL-37: a multitask antimicrobial peptide. (2010) pubmed
- Significance of the LL-37 Peptide Delivered from Human Cathelicidin in the Pathogenesis, Treatment, and Diagnosis of Sepsis. (2025) pubmed
- The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. (2005) pubmed
- The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections. (2010) pubmed
- SP-LL-37, human antimicrobial peptide, enhances disease resistance in transgenic rice. (2017) pubmed
- Cubosomes for topical delivery of the antimicrobial peptide LL-37. (2019) pubmed
- The human LL-37 peptide exerts antimicrobial activity against Legionella micdadei interacting with membrane phospholipids. (2022) pubmed
- Insight into the Mechanism of Interactions between the LL-37 Peptide and Model Membranes of Legionella gormanii Bacteria. (2023) pubmed
- Chitosan hydrogel encapsulated with LL-37 peptide promotes deep tissue injury healing in a mouse model. (2020) pubmed